Artemis Investment Management LLP increased its position in shares of UnitedHealth Group Inc (NYSE:UNH) by 8.0% in the 3rd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 433,220 shares of the healthcare conglomerate’s stock after purchasing an additional 32,213 shares during the period. UnitedHealth Group makes up approximately 1.7% of Artemis Investment Management LLP’s portfolio, making the stock its 13th largest position. Artemis Investment Management LLP’s holdings in UnitedHealth Group were worth $84,824,000 at the end of the most recent quarter.
Other institutional investors also recently modified their holdings of the company. Blue Chip Partners Inc. acquired a new stake in UnitedHealth Group during the second quarter worth approximately $110,000. Kings Point Capital Management boosted its position in UnitedHealth Group by 27.9% during the first quarter. Kings Point Capital Management now owns 687 shares of the healthcare conglomerate’s stock worth $113,000 after acquiring an additional 150 shares during the last quarter. Bruderman Asset Management LLC acquired a new stake in UnitedHealth Group during the second quarter worth approximately $114,000. Mitsubishi UFJ Securities Holdings Co. Ltd. boosted its position in UnitedHealth Group by 433.3% during the second quarter. Mitsubishi UFJ Securities Holdings Co. Ltd. now owns 640 shares of the healthcare conglomerate’s stock worth $119,000 after acquiring an additional 520 shares during the last quarter. Finally, BDO Wealth Advisors LLC acquired a new stake in UnitedHealth Group during the second quarter worth approximately $121,000. 86.01% of the stock is owned by institutional investors.
UnitedHealth Group Inc (NYSE UNH) opened at $228.64 on Friday. The company has a debt-to-equity ratio of 0.52, a quick ratio of 0.70 and a current ratio of 0.70. The stock has a market cap of $221,060.00, a PE ratio of 25.98, a price-to-earnings-growth ratio of 1.53 and a beta of 0.66. UnitedHealth Group Inc has a one year low of $156.09 and a one year high of $231.77.
UnitedHealth Group (NYSE:UNH) last released its earnings results on Tuesday, October 17th. The healthcare conglomerate reported $2.66 EPS for the quarter, topping analysts’ consensus estimates of $2.57 by $0.09. UnitedHealth Group had a net margin of 4.50% and a return on equity of 21.52%. The business had revenue of $50.32 billion for the quarter, compared to the consensus estimate of $50.38 billion. During the same period in the previous year, the firm earned $2.17 EPS. The business’s revenue for the quarter was up 8.7% on a year-over-year basis. equities research analysts predict that UnitedHealth Group Inc will post 9.99 earnings per share for the current fiscal year.
A number of equities analysts have weighed in on the stock. Evercore ISI reissued an “outperform” rating and issued a $255.00 target price (up previously from $235.00) on shares of UnitedHealth Group in a research note on Friday. Goldman Sachs Group started coverage on shares of UnitedHealth Group in a research note on Wednesday, January 3rd. They set a “buy” rating and a $269.00 price target on the stock. Credit Suisse Group reaffirmed a “buy” rating on shares of UnitedHealth Group in a research note on Wednesday, December 27th. Cantor Fitzgerald reaffirmed a “buy” rating and set a $235.00 price target on shares of UnitedHealth Group in a research note on Monday, December 25th. Finally, ValuEngine downgraded shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a research note on Thursday, December 7th. Three equities research analysts have rated the stock with a hold rating and twenty-five have assigned a buy rating to the stock. The stock presently has a consensus rating of “Buy” and a consensus price target of $229.54.
In related news, CEO Larry C. Renfro sold 22,598 shares of the business’s stock in a transaction that occurred on Friday, December 15th. The shares were sold at an average price of $221.75, for a total transaction of $5,011,106.50. Following the transaction, the chief executive officer now directly owns 195,314 shares of the company’s stock, valued at $43,310,879.50. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Michele J. Hooper sold 5,000 shares of the business’s stock in a transaction that occurred on Monday, December 4th. The shares were sold at an average price of $222.20, for a total transaction of $1,111,000.00. Following the transaction, the director now directly owns 36,989 shares in the company, valued at $8,218,955.80. The disclosure for this sale can be found here. Insiders sold a total of 34,630 shares of company stock worth $7,669,416 over the last quarter. Insiders own 0.89% of the company’s stock.
About UnitedHealth Group
UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.